Clinical Trials Logo

Filter by:
NCT ID: NCT04860206 Completed - Covid19 Clinical Trials

Post COVID19 Functional and Cognitive Assessments

PostCovidZRS
Start date: January 5, 2021
Phase:
Study type: Observational

The main objective of the proposed study is to evaluate the impact of coronavirus (2019-nCoV), hereafter COVID -19, on patients' loss of functional capacity after completion of hospital treatment. Specifically, the research will focus on examining changes in musculoskeletal, cardiovascular, and respiratory function, as well as motor control. In addition, we aim to evaluate rehabilitation treatments after recovery from COVID -19 and consider additional preventive measures based on previous experience.

NCT ID: NCT04859907 Completed - Craniotomy Clinical Trials

Bone Flap Fixation Systems For Craniotomy Procedures

LOOP2
Start date: March 19, 2021
Phase: N/A
Study type: Interventional

Clinical investigation to compare the clinical safety and performance of a clamp-like device for craniotomy closure, with the standard of care system, titanium plates and screws.

NCT ID: NCT04853030 Completed - Type 1 Diabetes Clinical Trials

Fast Advanced Closed-Loop Therapy

FACT
Start date: April 6, 2021
Phase: N/A
Study type: Interventional

A double-blind, multinational, multicenter, randomised, 2-period crossover study to assess the efficacy and safety of advanced closed-loop insulin delivery with Minimed 670G 4.0 system comparing Faster Insulin Aspart to Standard Insulin Aspart therapy over 4 weeks in active children and adolescents with type 1 diabetes.

NCT ID: NCT04849689 Completed - Body Weight Clinical Trials

WFPB Lifestyle and Muscle Mass Preservation

WFPBmuscle
Start date: April 12, 2021
Phase:
Study type: Observational

Body fat (BF) and muscle mass showed opposing association with mortality. Whole-food, plant-based (WFPB) lifestyle programs has been on the rise lately especially due to impressive health benefits. The results of research on the effectiveness of popular weight loss diets in obese subjects showed 20 to 30% loss of lean muscle mass within to the total body weight loss, whereas in the whole-food, plant-based (vegan) diet the loss was up to 42%. Therefore, an open research problem is to find a way how to improve body composition in an effective and healthy way (i.e., losing of excess BF while maintaining muscle mass as much as possible) but still using stric plant-based (vegan) diet. Investigators will perform retrospective analysis of measurements of body composition and phase angle values of aprox. 200 participants who were on a WFPB lifestyle program from 2016 to 2021 and performed two successive measurements (initial and follow up (FU)), without body mass index (BMI) limitation on same medically approved and calibrated bioelectrical impedance (Tanita 780 S MA, Tokyo, Japan) and were not yet included in our previous studies. A WFPB lifestyle program were consisted of nutrition (i), (ii) physical activity and (iii) support system. Primary outcome include the following measures: BF % and FFM and to examine the change from initial values to FU values (by gender), according BMI classification (e.g,, normal, pre-obese and obese) with subanalysis for those participants who lost up to 5 kg/more and those who lost 5 kg or more of body weight.

NCT ID: NCT04818905 Completed - Blood Pressure Clinical Trials

Helichrysum Italicum Infusion Ingestion in Humans

SMILJ
Start date: June 15, 2020
Phase: N/A
Study type: Interventional

The study evaluates the acute effects of Helichrysum italicum on resting energy expenditure and substrate oxidation in humans. The resting energy expenditure and substrate oxidation will be measured by indirect calorimetry at baseline and after ingestion of either Helichrysum italicum infusion or hot water.

NCT ID: NCT04812119 Completed - Clinical trials for CTNNB1 Gene Mutation

Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation

Gen-Phe CTNNB1
Start date: March 1, 2021
Phase:
Study type: Observational

The aim of this study is to explore and define the correlations between genotype and phenotype in patients with CTNNB1 mutations as well as monitor and survey the natural history of the CTNNB1 syndrome.

NCT ID: NCT04782921 Completed - Xenograft Model Clinical Trials

Papillae Tunneling Techniques in the Treatment of Isolated Intrabony Defects

PTT
Start date: March 3, 2020
Phase: N/A
Study type: Interventional

Papillae tunneling techniques (PTT) are a new approach toward regeneration of isolated intrabony defects. Compared to regular papillae preservation techniques, PTT rely on complete preservation of involved interdental papillae, providing optimal healing environment for periodontal wound. Surgical access is therefore gained either by vertical incision in vestibulum, or by short releasing incision on adjacent tooth. Interdental tissue is then carefully raised in a full thickness manner by tunneling instruments, root surface thoroughly cleaned by the ultrasound scaler or Gracey curettes and defect filled with the biomaterial of choice. While the success and aesthetic results of non-incised papillae techniques are well documented, no paper so far compared clinical results of papillae preservation techniques with different biomaterials. Therefore, the aim of our study is to compare gain of clinical attachment level (defined by sum of pocket probing depth and recession) to regular papillae preservation techniques, and to prove non-inferiority of Gel 40® (collagen matrix, loaded with micronized heterologous bone) to Gen-Os® (granulated cortico-cancellous heterologous bone mix). Secondary objectives include analysis of aesthetic parameters - differences in recession and tip of the papillae location before and after the treatment.

NCT ID: NCT04780074 Completed - Clinical trials for Bioavailability of Coenzyme Q10

Comparative Single-dose Bioavailability Study of Different CoQ10 Formulations

Start date: February 28, 2021
Phase: N/A
Study type: Interventional

The single-center, randomized, open-label, five-period crossover single-dose bioavailability study with five CoQ10 formulations

NCT ID: NCT04762927 Completed - Clinical trials for Musculoskeletal Diseases

Metric Properties of de Morton Mobility Index

DEMMIURIS
Start date: January 1, 2021
Phase:
Study type: Observational

Metric properties (convergent validity, predict validity, known-groups validity, responsiveness, floor and ceiling effects, minimal clinically important difference) of the de Morton Mobility Index (DEMMI) in patients with musculoskeletal impairments undergoing impatient rehabilitation will be investigated.

NCT ID: NCT04721002 Completed - Clinical trials for Multiple Myeloma (MM)

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

MEDICI
Start date: July 7, 2021
Phase:
Study type: Observational

Multiple myeloma (MM) is a rare cancer caused by abnormal survival of plasma cells (blood cells). Most trial participants with MM relapse (cancer has come back) or become non- responsive to treatment and remission gets shorter after each line of treatment. This is a study to assess t(11;14) and BCL2 expression in adult participants with newly diagnosed and relapsed/refractory (R/R) MM. Approximately 500 adult participants with newly confirmed or relapsed/refractory (R/R) multiple myeloma (MM) will be enrolled in around 15-20 countries. Participants will receive standard of care while participating in this study. No drug will be administered as a part of this study. Participants will attend regular visits during the course of the study at a hospital or clinic and will be asked to provide bone marrow and blood samples.